Dr Muhammad Babar Aslam, MBBS, FRCPATH, MBA (Health care) is a consultant pathologist in Betsi Cadwaladr University Health Board. He had special interest in using digital pathology and AI platforms to improve the services across all the specialties and had led innovative projects like all Wales AI deployment in prostatic pathology followed by breast, Upper GI, and pan cancer AI projects. He had various management roles in the NHS. Currently, he is also national clinical lead for Wales to support digital pathology and AI implementation projects. 

Dr David M Bailey MB BS FRCPath is a consultant histopathologist and Clinical Lead for Cellular Pathology at North West Anglia NHS Foundation Trust (NWAngliaFT).

In my NHS consultant role, I have 28 years’ experience as a general histopathologist and autopsy pathologist. I am the breast pathology lead for NWAngliaFT and was a founder member of the British Association of Urological Pathologists. I have previously published best practice guidance for prostate pathology and taught on FRCPath part 2 courses.  I introduced digital histopathology and AI-assisted reporting to the Trust, and since September 2024, have been NWAngliaFT site lead for the Ibex Galen Breast biopsy AI algorithm multi-centre UK implementation trial following a successful funding bid to NIHR.

I held several key positions at the Royal College of Pathologists including Vice President for Communications and International Affairs (2014-17) and Director of Training and Assessment (2010-14). I led pathology training and service development projects in Iraq, Pakistan, Sudan and sub-Saharan Africa. I was the lead author for the RCPath histopathology training curriculum (2010) and introduced stand-alone Certificates for Higher Autopsy and Cervical Cytology Training.

I have held posts as Clinical Director for the ME5 Pathology Network, Regional Clinical Lead for Pathology for NHS East of England, and director roles at NWAngliaFT for the Family and Integrated Support Services and General and Specialty Medicine Divisions.

My first consultant role was in Buckinghamshire where I spent 12 years as the training programme director for the Oxford Histopathology training programme, and five years as Associate Postgraduate Dean in the Oxford Deanery. I was also worked as a performance coach and mentor for the Deanery professional development unit which supported doctors in difficulty at all levels.

Professor Michael Osborn studied medicine at Guys & St Thomas Hospitals, London qualifying in 1995. He became a member of the Royal College of Surgeons in 2000 and a Fellow of the Royal College of Pathologists in 2004. Currently he works as a consultant histopathologist for North West London Pathology where he is Clinical Director. His working time is divided between post mortems, diagnostic gastrointestinal histopathology, and teaching. He also has a significant role for NHSE for whom he is National Specialty Adviser (NSA) for Pathology – Sustainability & Resilience & Clinical Lead for Pathology – London Region. He also runs an intercalated BSc “Humanities, Philosophy & Law” at Imperial College, London. He was the elected President of the Royal College of Pathologists (RCPath) in 2020 ending his term in 2023, having previously been on the RCPath Council and having had a variety of college roles including chair of their Cellular Pathology Speciality Advisory Committee and Death Investigation Committee. He became a Professor of Practice at Imperial College in 2021.

Prof Darren Treanor MB BSc (Computing) MD PhD is a consultant pathologist at Leeds Teaching Hospitals NHS Trust, honorary professor of pathology at the University of Leeds, adjunct professor in digital pathology at Linköping University, Sweden and Digital Histopathology Lead for the Royal College of Pathologists. He is a clinical director of the UKRI Centre for Doctoral Training in Artificial Intelligence in Healthcare at the University of Leeds and Director of the UK National Pathology Imaging Co-operative.

Dual qualified in medicine and computing, Prof Treanor runs the Leeds virtual pathology project, with a multi-disciplinary team working in digital pathology research and innovation. He has co-authored over 180 papers in the medical and computing literature, most of them concerned with the application or development of digital pathology in clinical and preclinical areas.

He is director of the National Pathology Imaging Co-operative, a £110m Industry-Academia-NHS collaboration to deploy digital pathology across more than 20 labs, and across 2 national networks to support sarcoma/bone and paediatric tumour diagnosis. NPIC will use this infrastructure to develop and test artificial intelligence systems to diagnose cancer, covering the whole AI lifecycle from development through evaluation to deployment.

At Linköping his research includes the clinical adoption and validation of digital pathology in a fully digitised department, and the development and implementation of AI.

Other research activities include 3D tissue reconstruction, image analysis, colour measurement/ correction and the use of digital pathology in education and training.

Further details are available at http://www.virtualpathology.leeds.ac.uk and https://npic.ac.uk 

Jeroen van der Laak is professor of computational Pathology at the department of Pathology of the Radboud University Medical Center in Nijmegen, The Netherlands and guest professor at the Center for Medical Image Science and Visualization (CMIV) in Linköping, Sweden. His research focuses on the use of artificial intelligence (AI) for analysis of digitized histopathological images. His research group was among the first to show the large potential of so-called deep learning algorithms for analysis of whole slide images. Further research focused on the use of AI to support pathology diagnostics in areas such as breast cancer grading and Banff scoring in transplant kidney biopsies. He coordinated several well-known grand challenges (CAMELYON, MONKEY). Dr van der Laak co-authored over 200 peer-reviewed publications and was previously member of the board of directors of the Digital Pathology Association and is chair of the 'AI in Pathology' taskforce of the European Society of Pathology. He received research funding from, among others, the European Union, the Dutch Cancer Society and the Dutch government. Dr van der Laak is coordinator of the Bigpicture project, is USCAP Nathan Kaufman laureate and recipient of the AMMODO award for groundbreaking science. In 2021, he founded the Radboudumc spinoff Aiosyn, for which he is CSO.

Clare Verrill is Professor of Cellular Pathology and Artificial Intelligence with the Nuffield Department of Surgical Sciences at the University of Oxford and Honorary Consultant Cellular Pathologist with Oxford University Hospitals NHS Foundation Trust. Her sub speciality is urological pathology and has her own research group focussing on digital pathology and AI. The NHS Cellular Pathology Laboratory in Oxford has achieved the milestone of scanning 100% of surgical histology workload under her oversight. She was previously Oxford Principal Investigator for Oxford PathLAKE (one of the UK Government’s AI Centres of Excellence) and has worked with computer science partners to develop AI. She is the Principal Investigator of The Articulate Pro study, evaluating Paige Prostate AI in NHS settings and Principal Investigator of the Vanguard Path study, evaluating Artera AI. She is a previous Turing Fellow with the Alan Turing Institute.